Related Experiment Video
Updated: May 7, 2026

Immunostaining for DNA Modifications: Computational Analysis of Confocal Images
Published on: September 7, 2017
Loss of LDOC1 expression by promoter methylation in cervical cancer cells
Marie-Luise Buchholtz1, Julia Jückstock, Elena Weber
1Department of Obstetrics and Gynecology, Ludwig Maximilians University, Munich, Germany.
Abstract:
Cervical cancer lacks reliable prognostic factors for both progression and chemotherapeutic responsiveness. The expression of the LDOC1 tumor suppressor candidate was therefore investigated. In four of six cervical cancer cell lines tested, expression of LDOC1 was silenced. Downregulation of LDOC1 could also be shown in biopsies of cervical cancer specimens. PCR-based promoter methylation analysis revealed a significant association between promoter methylation and the loss of LDOC1 expression, which could be reverted by DNA methyltransferase inhibitors. This indicates that silencing of LDOC1 is a frequent event in cervical cancer and may be of interest as a molecular marker in cervical cancer.
Insights
Loss of the LDOC1 tumor suppressor is frequent in cervical cancer, often due to promoter methylation. This silencing may serve as a valuable molecular marker for cervical cancer progression and treatment response.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cervical cancer lacks reliable prognostic factors for disease progression and response to chemotherapy.
- The role of the LDOC1 tumor suppressor candidate in cervical cancer is not well understood.
Purpose of the Study:
- To investigate the expression of the LDOC1 tumor suppressor candidate in cervical cancer.
- To determine the mechanism of LDOC1 downregulation and its potential as a molecular marker.
Main Methods:
- Analysis of LDOC1 expression in cervical cancer cell lines and patient biopsies.
- PCR-based promoter methylation analysis.
- Treatment with DNA methyltransferase inhibitors to assess reversibility of silencing.
Main Results:
- LDOC1 expression was silenced in four out of six tested cervical cancer cell lines.
- Downregulation of LDOC1 was observed in cervical cancer tissue specimens.
- A significant association was found between LDOC1 promoter methylation and loss of LDOC1 expression.
- Silencing of LDOC1 was reversible upon treatment with DNA methyltransferase inhibitors.
Conclusions:
- LDOC1 silencing is a frequent event in cervical cancer.
- Promoter methylation is a key mechanism for LDOC1 silencing in cervical cancer.
- LDOC1 may represent a potential molecular marker for cervical cancer prognosis and therapeutic targeting.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
MicroRNAs
MicroRNAs

